Fuzzyfuzzy
2021-07-23
Lol
UPDATE 1-U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":172735521,"tweetId":"172735521","gmtCreate":1626993626863,"gmtModify":1631887626678,"author":{"id":3576849200483737,"idStr":"3576849200483737","authorId":3576849200483737,"authorIdStr":"3576849200483737","name":"Fuzzyfuzzy","avatar":"https://static.tigerbbs.com/83fbe5cf3fa66c4ec89abe62d2856950","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Lol</p></body></html>","htmlText":"<html><head></head><body><p>Lol</p></body></html>","text":"Lol","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/172735521","repostId":2153706666,"repostType":2,"repost":{"id":"2153706666","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626980650,"share":"https://www.laohu8.com/m/news/2153706666?lang=&edition=full","pubTime":"2021-07-23 03:04","market":"us","language":"en","title":"UPDATE 1-U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2153706666","media":"Reuters","summary":"(Adds comments from meeting) July 22 (Reuters) - Despite reports of a rare neurological disorder a","content":"<html><body><p>(Adds comments from meeting)</p><p> July 22 (Reuters) - Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh the risks, a U.S. Centers for Disease Control and Prevention advisory panel said on Thursday.</p><p> The U.S. Food and Drug Administration last week added a warning to its fact sheet for J&J's single-shot vaccine saying that data suggests there is an increased risk of Guillain-Barré syndrome <a href=\"https://laohu8.com/S/GBS\">$(GBS)$</a> in the six weeks after vaccination. </p><p> The CDC advisory panel evaluated the J&J vaccine's risks and benefits after these preliminary reports of GBS from people who have gotten the shot. </p><p> Given the possible association between GBS and the vaccine, CDC will update its considerations for the use of J&J's vaccine to say that patients with a history of GBS should first look at the availability of two-shot mRNA-based vaccines from Pfizer Inc</p><p> /<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> and Moderna , an agency official said. </p><p> The FDA cited 100 preliminary reports of GBS in J&J vaccine recipients including 95 serious cases that required hospitalization and <a href=\"https://laohu8.com/S/AONE.U\">one</a> reported death.</p><p> J&J on Thursday said the known benefits on its vaccine outweigh known potential risks. </p><p> Members of a work group of the CDC Advisory Committee on Immunization Practices (ACIP) expressed \"strong support\" for continued use of J&J vaccine, the CDC's Sarah Mbaeyi said during the panel meeting. </p><p> The CDC will also update some of its communication materials on the vaccine, including information for medical providers on talking to patients about vaccine safety and frequently asked questions, Mbaeyi added.</p><p> (Reporting by Manojna Maddipatla in Bengaluru; Editing by Will Dunham)</p><p>((manojna.kalyani@thomsonreuters.com; +91 8061822700;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-23 03:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds comments from meeting)</p><p> July 22 (Reuters) - Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh the risks, a U.S. Centers for Disease Control and Prevention advisory panel said on Thursday.</p><p> The U.S. Food and Drug Administration last week added a warning to its fact sheet for J&J's single-shot vaccine saying that data suggests there is an increased risk of Guillain-Barré syndrome <a href=\"https://laohu8.com/S/GBS\">$(GBS)$</a> in the six weeks after vaccination. </p><p> The CDC advisory panel evaluated the J&J vaccine's risks and benefits after these preliminary reports of GBS from people who have gotten the shot. </p><p> Given the possible association between GBS and the vaccine, CDC will update its considerations for the use of J&J's vaccine to say that patients with a history of GBS should first look at the availability of two-shot mRNA-based vaccines from Pfizer Inc</p><p> /<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> and Moderna , an agency official said. </p><p> The FDA cited 100 preliminary reports of GBS in J&J vaccine recipients including 95 serious cases that required hospitalization and <a href=\"https://laohu8.com/S/AONE.U\">one</a> reported death.</p><p> J&J on Thursday said the known benefits on its vaccine outweigh known potential risks. </p><p> Members of a work group of the CDC Advisory Committee on Immunization Practices (ACIP) expressed \"strong support\" for continued use of J&J vaccine, the CDC's Sarah Mbaeyi said during the panel meeting. </p><p> The CDC will also update some of its communication materials on the vaccine, including information for medical providers on talking to patients about vaccine safety and frequently asked questions, Mbaeyi added.</p><p> (Reporting by Manojna Maddipatla in Bengaluru; Editing by Will Dunham)</p><p>((manojna.kalyani@thomsonreuters.com; +91 8061822700;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153706666","content_text":"(Adds comments from meeting) July 22 (Reuters) - Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh the risks, a U.S. Centers for Disease Control and Prevention advisory panel said on Thursday. The U.S. Food and Drug Administration last week added a warning to its fact sheet for J&J's single-shot vaccine saying that data suggests there is an increased risk of Guillain-Barré syndrome $(GBS)$ in the six weeks after vaccination. The CDC advisory panel evaluated the J&J vaccine's risks and benefits after these preliminary reports of GBS from people who have gotten the shot. Given the possible association between GBS and the vaccine, CDC will update its considerations for the use of J&J's vaccine to say that patients with a history of GBS should first look at the availability of two-shot mRNA-based vaccines from Pfizer Inc /BioNTech SE and Moderna , an agency official said. The FDA cited 100 preliminary reports of GBS in J&J vaccine recipients including 95 serious cases that required hospitalization and one reported death. J&J on Thursday said the known benefits on its vaccine outweigh known potential risks. Members of a work group of the CDC Advisory Committee on Immunization Practices (ACIP) expressed \"strong support\" for continued use of J&J vaccine, the CDC's Sarah Mbaeyi said during the panel meeting. The CDC will also update some of its communication materials on the vaccine, including information for medical providers on talking to patients about vaccine safety and frequently asked questions, Mbaeyi added. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Will Dunham)((manojna.kalyani@thomsonreuters.com; +91 8061822700;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":74,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/172735521"}
精彩评论